These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10758942)

  • 1. Chronic treatment with phentermine combined with fenfluramine lowers plasma serotonin.
    Rothman RB; Redmon JB; Raatz SK; Kwong CA; Swanson JE; Bantle JP
    Am J Cardiol; 2000 Apr; 85(7):913-5, A10. PubMed ID: 10758942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of combinations of drugs for treatment of obesity: body weight and echocardiographic status.
    Whigham LD; Dhurandhar NV; Rahko PS; Atkinson RL
    Int J Obes (Lond); 2007 May; 31(5):850-7. PubMed ID: 17146452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The combination of phentermine and fenfluramine reduced cocaine withdrawal symptoms in an open trial.
    Kampman KM; Rukstalis M; Pettinati H; Muller E; Acosta T; Gariti P; Ehrman R; O'Brien CP
    J Subst Abuse Treat; 2000 Jul; 19(1):77-9. PubMed ID: 10867304
    [No Abstract]   [Full Text] [Related]  

  • 4. Combined phentermine/fenfluramine administration and central serotonin neurons.
    Baumann MH; Rothman RB
    Synapse; 1998 Apr; 28(4):339-42. PubMed ID: 9517842
    [No Abstract]   [Full Text] [Related]  

  • 5. [Valvular heart disease and primary pulmonary hypertension associated with fenfluramine-phentermine].
    Wolf I; Mouallem M; Farfel Z
    Harefuah; 1998 Dec; 135(11):515-7. PubMed ID: 10911468
    [No Abstract]   [Full Text] [Related]  

  • 6. Combination of the dopaminergic agent, phentermine, and the serotonergic agent, fenfluramine, in the treatment of cocaine dependence.
    Kampman KM; Volpicelli J
    J Subst Abuse Treat; 1997; 14(4):401-4. PubMed ID: 9368218
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of phentermine and fenfluramine on alcohol consumption and alcohol withdrawal seizures in rats.
    Halladay AK; Fisher H; Wagner GC
    Alcohol; 2000 Jan; 20(1):19-29. PubMed ID: 10680713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind clinical trial in weight control. Use of fenfluramine and phentermine alone and in combination.
    Weintraub M; Hasday JD; Mushlin AI; Lockwood DH
    Arch Intern Med; 1984 Jun; 144(6):1143-8. PubMed ID: 6375610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valvular heart disease associated with fenfluramine-phentermine.
    Redmon B; Raatz S; Bantle JP
    N Engl J Med; 1997 Dec; 337(24):1773-4; author reply 1775. PubMed ID: 9411249
    [No Abstract]   [Full Text] [Related]  

  • 10. Diet drug-related cardiac valve disease: the Mayo Clinic echocardiographic laboratory experience.
    Teramae CY; Connolly HM; Grogan M; Miller FA
    Mayo Clin Proc; 2000 May; 75(5):456-61. PubMed ID: 10807073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose and duration of fenfluramine-phentermine therapy impacts the risk of significant valvular heart disease.
    Lepor NE; Gross SB; Daley WL; Samuels BA; Rizzo MJ; Luko SP; Hickey A; Buchbinder NA; Naqvi TZ
    Am J Cardiol; 2000 Jul; 86(1):107-10. PubMed ID: 10867106
    [No Abstract]   [Full Text] [Related]  

  • 12. Echocardiographic improvement over time after cessation of use of fenfluramine and phentermine.
    Hensrud DD; Connolly HM; Grogan M; Miller FA; Bailey KR; Jensen MD
    Mayo Clin Proc; 1999 Dec; 74(12):1191-7. PubMed ID: 10593346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic induction of weight loss to treat type 2 diabetes.
    Redmon JB; Raatz SK; Kwong CA; Swanson JE; Thomas W; Bantle JP
    Diabetes Care; 1999 Jun; 22(6):896-903. PubMed ID: 10372238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aminorex to fen/phen: an epidemic foretold.
    Fishman AP
    Circulation; 1999 Jan 5-12; 99(1):156-61. PubMed ID: 9884392
    [No Abstract]   [Full Text] [Related]  

  • 15. The serotonergic appetite suppressant fenfluramine. Reappraisal and rejection.
    Curzon G; Gibson EL
    Adv Exp Med Biol; 1999; 467():95-100. PubMed ID: 10721044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of cocaine self-administration by fluoxetine or D-fenfluramine combined with phentermine.
    Glatz AC; Ehrlich M; Bae RS; Clarke MJ; Quinlan PA; Brown EC; Rada P; Hoebel BG
    Pharmacol Biochem Behav; 2002; 71(1-2):197-204. PubMed ID: 11812523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of phentermine and fenfluramine on extracellular dopamine and serotonin in rat nucleus accumbens: therapeutic implications.
    Baumann MH; Ayestas MA; Dersch CM; Brockington A; Rice KC; Rothman RB
    Synapse; 2000 May; 36(2):102-13. PubMed ID: 10767057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Development of pulmonary hypertension and multi-valvular damage caused by appetite depressants].
    Goldstein SE; Levy Y; Shoenfeld Y
    Harefuah; 1998 Dec; 135(11):489-92, 568. PubMed ID: 10911459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial.
    Lagae L; Sullivan J; Knupp K; Laux L; Polster T; Nikanorova M; Devinsky O; Cross JH; Guerrini R; Talwar D; Miller I; Farfel G; Galer BS; Gammaitoni A; Mistry A; Morrison G; Lock M; Agarwal A; Lai WW; Ceulemans B;
    Lancet; 2019 Dec; 394(10216):2243-2254. PubMed ID: 31862249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose effect of fenfluramine-phentermine in the production of valvular heart disease.
    Tovar EA; Landa DW; Borsari BE
    Ann Thorac Surg; 1999 Apr; 67(4):1213-4. PubMed ID: 10320298
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.